Allspring Global Investments
CPRX

Allspring Global Investments’s Catalyst Pharmaceutical CPRX Stock Holding History

Allspring Global Investments’s Portfolio CPRX Stock Details CPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.91M Buy
117,088
+94,933
+428% +$2.26M ﹤0.01% 983
2025
Q4 		$513K Buy
22,155
+1,953
+10% +$43.5K ﹤0.01% 1365
2025
Q3 		$398K Sell
20,202
-205
-1% -$4.22K ﹤0.01% 1409
2025
Q2 		$432K Sell
20,407
-152,777
-88% -$3.61M ﹤0.01% 1386
2025
Q1 		$4.14M Sell
173,184
-244,148
-59% -$5.5M 0.01% 971
2024
Q4 		$8.71M Buy
417,332
+50,888
+14% +$1.09M 0.01% 805
2024
Q3 		$7.28M Buy
366,444
+217,956
+147% +$4.04M 0.01% 846
2024
Q2 		$2.3M Buy
148,488
+5,007
+3% +$77.9K ﹤0.01% 1139
2024
Q1 		$2.29M Sell
143,481
-11,753
-8% -$177K ﹤0.01% 1153
2023
Q4 		$2.61M Sell
155,234
-320,168
-67% -$4.38M ﹤0.01% 1108
2023
Q3 		$5.56M Sell
475,402
-48,676
-9% -$651K 0.01% 934
2023
Q2 		$7.04M Buy
524,078
+93,311
+22% +$1.34M 0.01% 892
2023
Q1 		$7.14M Buy
430,767
+12,873
+3% +$212K 0.01% 887
2022
Q4 		$7.77M Buy
417,894
+207,412
+99% +$3.19M 0.01% 857
2022
Q3 		$2.7M Sell
210,482
-575,082
-73% -$6.82M ﹤0.01% 1148
2022
Q2 		$5.51M Sell
785,564
-292,687
-27% -$2.15M 0.01% 963
2022
Q1 		$8.94M Buy
1,078,251
+634,522
+143% +$4.49M 0.01% 922
2021
Q4 		$3M Buy
+443,729
New +$2.92M ﹤0.01% 1351

Other funds holding CPRX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Allspring Global Investments's CPRX Position: Q1 2026 in Review

Allspring Global Investments increased its Catalyst Pharmaceutical (CPRX) stake by 428% in Q1 2026, buying an estimated $2.26M and bringing the position to 117,088 shares worth $2.91M. The position accounts for ﹤0.01% of the portfolio, ranked #983.

Allspring Global Investments first reported a position in CPRX in Q4 2021 and has held it in 18 quarters since. The position peaked at $8.94M in Q1 2022. 380 funds tracked by Wall St. Rank hold CPRX as of Q1 2026.

  • Allspring Global Investments held 117,088 shares of Catalyst Pharmaceutical worth $2.91M as of Q1 2026.
  • Allspring Global Investments bought 94,933 Catalyst Pharmaceutical shares in Q1 2026, an estimated $2.26M.
  • Catalyst Pharmaceutical made up ﹤0.01% of Allspring Global Investments's portfolio in Q1 2026, its #983 holding.
  • Allspring Global Investments first reported a position in Catalyst Pharmaceutical in Q4 2021 and has held it in 18 quarters since.
  • Allspring Global Investments's Catalyst Pharmaceutical position peaked at $8.94M in Q1 2022.
  • 380 funds tracked by Wall St. Rank held Catalyst Pharmaceutical as of Q1 2026.

Based on Allspring Global Investments's 13F filing for Q1 2026, filed 5 May 2026.